|
|
Volumn 172, Issue 7, 2005, Pages 865-
|
|
US senator alleges FDA tried to prevent Adderall XR withdrawal in Canada.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMPHETAMINE DERIVATIVE;
CENTRAL STIMULANT AGENT;
SLI381;
ADULT;
ARTICLE;
ATTENTION DEFICIT DISORDER;
CANADA;
CHILD;
DRUG CONTROL;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
ORGANIZATION;
ORGANIZATION AND MANAGEMENT;
PUBLIC HEALTH;
UNITED STATES;
ADULT;
AMPHETAMINES;
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;
CANADA;
CENTRAL NERVOUS SYSTEM STIMULANTS;
CHILD;
DRUG AND NARCOTIC CONTROL;
HUMANS;
NATIONAL HEALTH PROGRAMS;
ORGANIZATIONAL CULTURE;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 23044525078
PISSN: None
EISSN: 14882329
Source Type: Journal
DOI: 10.1503/cmaj.050266 Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
